| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
1,188 |
1,129 |
$1.05M |
| 92134 |
|
18,965 |
16,243 |
$334K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
9,390 |
8,905 |
$328K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
280 |
243 |
$247K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
3,651 |
3,609 |
$216K |
| J9035 |
Injection, bevacizumab, 10 mg |
5,021 |
4,577 |
$209K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
2,885 |
2,784 |
$112K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,443 |
1,397 |
$41K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
250 |
250 |
$16K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
232 |
230 |
$15K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
16 |
12 |
$13K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
91 |
87 |
$3K |
| 92250 |
|
31 |
30 |
$2K |
| 92201 |
|
97 |
97 |
$943.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
12 |
12 |
$911.00 |
| 76512 |
|
17 |
14 |
$686.99 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
33 |
33 |
$581.87 |